Platform
Company
Glucose and Diabetes
Review status
Currently under review
Pending specialist review and validation.
This test measures the amount of glucose, the main sugar in your blood, from sample types or analyzers outside the standard chemistry lab method. It is often performed on whole blood collected from an arterial, venous, or capillary source and may be analyzed on a blood gas or point‑of‑care device. The result reflects your current circulating glucose level at the time of collection.
“Other” indicates that the specimen type or testing platform differs from a routine serum or plasma glucose test. Because the sample matrix and instrument are different, results may not be identical to a standard laboratory plasma glucose, but they are designed to guide immediate clinical decisions when speed and access are priorities.
Your body relies on glucose for energy, especially your brain and muscles. Levels that are too high or too low can cause symptoms and may signal conditions such as diabetes, medication effects, or acute illness. This test helps your care team quickly assess your glucose status so they can respond to symptoms like feeling shaky, confusion, unusual thirst, frequent urination, or changes in vision.
Clinicians often order this form of glucose testing when rapid decisions are needed, such as in the emergency department, during surgery, in critical care, or for newborns. It can also help monitor treatment with insulin or other medicines, evaluate effects of intravenous dextrose, and assess stress responses during infections or after procedures.
Your result is interpreted in the context of how and when the sample was collected, your symptoms, recent meals or drinks, and any treatments you are receiving. Whole blood results from blood gas or point‑of‑care devices can differ from standard plasma measurements, so your clinician may confirm unexpected values with a lab plasma glucose or repeat testing.
If your glucose is higher than expected, your clinician will consider factors like recent meals, steroids, illness, or underlying diabetes, and may recommend confirmatory testing such as a fasting plasma glucose or an A1C, along with lifestyle or medication adjustments. If your glucose is lower than expected, they will consider symptoms, timing of your last meal, and medicines like insulin, and may advise a snack, closer monitoring, or additional lab tests. In newborns and critically ill patients, targets and follow‑up plans are individualized.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Eating or drinking, especially carbohydrates or sugary beverages, can raise glucose for several hours. Tell your care team when you last ate or had a drink so they can interpret the result correctly.
Glucose measured on whole blood using a blood gas or point‑of‑care device can read differently than standard plasma tests. Your team may compare or confirm with a laboratory plasma glucose when needed.
Delays before analysis or improper handling can let cells consume glucose and lower the measured value. Rapid analysis and correct collection technique reduce this effect.
Insulin, sulfonylureas, steroids, dextrose infusions, beta blockers, quinolones, and alcohol can raise or lower glucose or mask symptoms. Let your clinician know what you take and recent IV therapies.
Infections, trauma, surgery, heart events, and severe pain trigger stress hormones that can increase glucose temporarily, even in people without diabetes.
Newborns often have transitional glucose patterns, and critically ill patients may have individualized targets. High or low hematocrit can also affect some point‑of‑care meters.
Drawing blood from or near a line that recently delivered dextrose can falsely elevate results. Samples should be collected from an appropriate site away from infusions.
References